U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 23:37:37 GMT 2025
Edited
by admin
on Mon Mar 31 23:37:37 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
JEA93WJ5DG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
sotigalimab [INN]
Preferred Name English
SOTIGALIMAB
USAN   INN  
Official Name English
SOTIGALIMAB [USAN]
Common Name English
APX-005
Code English
APX-005M
Code English
IMMUNOGLOBULIN G1 (270-GLUTAMIC ACID, C-TERMINAL-LYSINE-CLIPPED), ANTI-(HUMAN CD40 ANTIGEN) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL APX005M .KAPPA.-CHAIN, DIMER
Common Name English
CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M
Common Name English
APX005M
Code English
Sotigalimab [WHO-DD]
Common Name English
EPI-0050
Code English
Classification Tree Code System Code
NCI_THESAURUS C133877
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
FDA ORPHAN DRUG 768220
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
FDA ORPHAN DRUG 830321
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
FDA ORPHAN DRUG 726619
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
Code System Code Type Description
CAS
2305607-45-6
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
PRIMARY
NCI_THESAURUS
C123734
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
PRIMARY
SMS_ID
300000032571
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
PRIMARY
FDA UNII
JEA93WJ5DG
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
PRIMARY
USAN
JK-152
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
PRIMARY
INN
11472
Created by admin on Mon Mar 31 23:37:37 GMT 2025 , Edited by admin on Mon Mar 31 23:37:37 GMT 2025
PRIMARY
From To
1_22 1_96
1_147 1_203
1_223 3_215
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
2_22 2_96
2_147 2_203
2_223 4_215
2_264 2_324
2_370 2_428
3_23 3_88
3_135 3_195
4_23 4_88
4_135 4_195
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_58
N 1_300
N 2_58
N 2_300
Related Record Type Details
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5
TARGET -> AGONIST
Agonist of the cell surface receptor CD40, with potential immunostimulatory and antineoplastic activities.
AGONIST
Related Record Type Details
SOTIGALIMAB
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_450] [2_450] C-TERMINUS LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966